e-learning
resources
ERJ
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pathogenicity of individual rhinovirus species during exacerbations of cystic fibrosis
Shah Amna, Connelly Michael, Whitaker Paul, McIntyre Chloe, Etherington Christine, Denton Miles, Hale Anthony, Harvala Heli, Simmonds Peter, Peckham Daniel G.
Source:
Eur Respir J 2015; 45: 1748-1751
Journal Issue:
June
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Shah Amna, Connelly Michael, Whitaker Paul, McIntyre Chloe, Etherington Christine, Denton Miles, Hale Anthony, Harvala Heli, Simmonds Peter, Peckham Daniel G.. Pathogenicity of individual rhinovirus species during exacerbations of cystic fibrosis. Eur Respir J 2015; 45: 1748-1751
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Frequency and pathogenicity of rhinovirus associated pulmonary exacerbations in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Respiratory viruses in adults with cystic fibrosis during stable and exacerbations
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019
Viral infections trigger exacerbations of cystic fibrosis in adults and children
Source: Eur Respir J 2012; 40: 510-512
Year: 2012
Respiratory infections in cystic fibrosis
Source: ERS Courses: Paediatric respiratory infections
Year: 2019
Differential interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015
Sputum bacterial concentrations and exacerbations of non cystic fibrosis bronchiectasis
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Role of stenotrophomonas maltophilia infection in CF pulmonary exacerbations
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Fosfomycin for pseudomonas related exacerbations of cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008
The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 28 (152) 190045; 10.1183/16000617.0045-2019
Year: 2019
Bacterial infection and lung function in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 615s
Year: 2005
Evolution of the infectious disease in cystic fibrosis (CF)
Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
Year: 2008
Cystic fibrosis patients have different microbiological colonization comparing to other bronchiectasis
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010
Emerging pathogens in cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66
Year: 2006
Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
Temperate bacteriophages of
pseudomonas aeruginosa
as markers of bacterial adaptation in CF and non-CF bronchiectasis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Susceptibility of problem respiratory pathogens to levofloxacin in cystic fibrosis (CF)
Source: Eur Respir J 2002; 20: Suppl. 38, 526s
Year: 2002
Azithromycin in chronic respiratory infections with
pseudomonas aeruginosa
in patients without cystic fibrosis
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Assessing response to treatment of exacerbations of bronchiectasis in adults
Source: Eur Respir J 2009; 33: 312-318
Year: 2009
Non-ABPA Aspergillus bronchitis in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: clinical issues
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept